NASDAQ: RANI - Rani Therapeutics Holdings, Inc.

六个月盈利: -70.01%
部门: Healthcare

促销时间表 Rani Therapeutics Holdings, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including large molecules, such as peptides, proteins, and antibodies.

更多详情
Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The company was incorporated in 2012 and is headquartered in San Jose, California.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

Выручка 0.000979
EBITDA -0.0261
Число акций ао 0.02551 млрд
P/S 4296.54
P/BV -43.53
EV/EBITDA -165.09
Цена ао 3.18
ISIN US7530181004
Сайт https://www.ranitherapeutics.com
Валюта usd
IPO date 2021-07-30
Sector Health Care
Industry Biotechnology
Валюта отчета usd
每日价格变化: 0% (2.12)
每周价格变化: -9.79% (2.35)
每月价格变化: -10.55% (2.37)
3个月内价格变化: -37.09% (3.37)
六个月内的价格变化: -70.01% (7.07)
每年价格变化: +5.47% (2.01)
3年内价格变化: -86.82% (16.09)
年初以来价格变化: +5.47% (2.01)
所有参数

低估

姓名 意义 年级
P/S 0 0
P/BV 3.31 5
P/E 0 0
EV/EBITDA -1.65 0
全部的: 3.13

效率

姓名 意义 年级
ROA, % -58.65 0
ROE, % -264.03 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.4611 10
全部的: 7.8

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 175.79 10
盈利能力 Ebitda, % 150.1 10
盈利能力 EPS, % -6.2 0
全部的: 6.6
更多详情

机构 体积 分享, %
Vanguard Group Inc 668347 2.57
Nan Fung Group Holdings Limited 493584 1.9
United Services Automobile Association 481300 1.85
Alphabet Inc. 448492 1.72
Bank of America Corporation 114259 0.44
Geode Capital Management, LLC 113629 0.44
Blackrock Inc. 63583 0.24
Lasry, Marc 62887 0.24
Alpha Square Group S, LLC 58946 0.23
King Luther Capital Management 56129 0.22

ETF 分享, % 本年盈利能力, % 股息, %
Dimensional International Core Equity 2 ETF 0.00033 12.593206296603 3.69996
Dimensional International Small Cap ETF 0.00065 13.318681318681 3.34747
Dimensional International Small Cap Value ETF 0.00059 13.61043194784 4.55441



导师 职称 支付 出生年份
Mr. Mir A. Imran Executive Chairman 80k 1956 (68 年)
Mr. Talat Imran CEO & Director 450k 1982 (42 年)
Mr. Svai S. Sanford Chief Financial Officer 416k 1970 (54 年)
Dr. Mir Hashim Chief Scientific Officer 416k 1960 (64 年)
Mr. Eric Groen General Counsel N/A 1971 (53 年)
Ms. Bella Vazquez Vice President of Human Resources N/A
Ms. Kate McKinley M.B.A. Chief Business Officer N/A 1977 (47 年)
Ms. Arvinder Dhalla Vice President of Clinical Development N/A

地址: United States, San Jose. CA, 2051 Ringwood Avenue - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.ranitherapeutics.com